Development of a Japanese version of the patient perceptions of deprescribing - Short form
- PMID: 39776881
- PMCID: PMC11702458
- DOI: 10.1002/jgf2.733
Development of a Japanese version of the patient perceptions of deprescribing - Short form
Abstract
Background: Deprescribing is a critical component of clinical practice, especially in geriatric medicine. Nevertheless, the attributes of patients who are prepared for, interested in, and could potentially benefit from deprescribing have not been well examined. The Patient Perceptions of Deprescribing (PPoD) evaluates patients' overall readiness for deprescribing and is complemented by an 11-item validated short form (SF-PPoD). The objective of this study was to develop a Japanese version of the SF-PPoD and assess its reliability and validity within Japanese older adults with polypharmacy.
Methods: The SF-PPoD was translated, back-translated, and assessed in a cognitive interview. We conducted a cross-sectional survey with 196 patients aged 65 years or older with five or more medications using the Japanese version to test for reliability and validity. We examined internal consistency and construct validity to determine if the Japanese sample responses reproduce the two subscales in the original SF-PPoD. Finally, we examined intra-person replicability using the intraclass correlation coefficient, in which 100 participants were invited and 93 participated.
Results: 118 males and 78 females, with a mean age of 79.2 [SD 6.5] years, completed the survey. Confirmatory factor analysis of the Japanese version of SF-PPoD revealed satisfactory structural validity with two-dimensional structure, "Motivation for Deprescribing" and "Primary Care Physician Relationship." Cronbach's alpha showed good internal consistency, and test-retest demonstrated acceptable intra-rater reliability.
Conclusions: We developed and validated a Japanese version of SF-PPoD with an 11-item, two-dimensional structure consistent with the original SF-PPoD. This scale may facilitate shared decision-making for medication optimization among older adults living with multimorbidity.
Keywords: deprescribing; geriatrics; patient perspectives; polypharmacy; primary health care; questionnaire.
© 2024 The Author(s). Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association.
Conflict of interest statement
KI has received grant funding from the Japan Agency for Medical Research and Development (AMED) outside the submitted work (grunt number 22FK0108512H001). AML has received grant funding from VA Health Systems Research and her time is supported by resources from the VA Boston Healthcare System. She has received compensation from the US Deprescribing Research Network and AHRQ for deprescribing related work. MK, MT, and SMA: none to declare. KI is an Editorial Board member of the Journal of General and Family Medicine and a co‐author of this article. To minimize bias, he was excluded from all editorial decision‐making related to the acceptance of this article for publication.
Figures


Similar articles
-
The Patient Perceptions of Deprescribing (PPoD) Survey: Short-Form Development.Drugs Aging. 2020 Dec;37(12):909-916. doi: 10.1007/s40266-020-00802-w. Epub 2020 Oct 7. Drugs Aging. 2020. PMID: 33026638
-
Cross-cultural adaptation and psychometric validation of a Spanish version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire.BMJ Open. 2022 Apr 21;12(4):e050678. doi: 10.1136/bmjopen-2021-050678. BMJ Open. 2022. PMID: 35450888 Free PMC article.
-
Translation, cross-cultural adaptation and validation of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire to Portuguese: Older adults version.Res Social Adm Pharm. 2023 Jan;19(1):123-132. doi: 10.1016/j.sapharm.2022.08.015. Epub 2022 Sep 5. Res Social Adm Pharm. 2023. PMID: 36115808
-
Validity and Reliability of the Japanese Version of the Örebro Musculoskeletal Pain Screening Questionnaire-Short Form for Chronic Low Back Pain.Pain Physician. 2022 Jul;25(4):E681-E688. Pain Physician. 2022. PMID: 35793192
-
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475. Health Technol Assess. 2022. PMID: 35894932 Free PMC article. Review.
References
-
- Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. - PubMed
-
- Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181–187. - PubMed
-
- Muria Subirats E, Ballesta Ors J, Clua Espuny JL, González Henares MA, Tomas Q, Panisello Tafalla A, et al. Longterm mortality among chronic complex patients with polypharmacy: results of community‐ based prospective study. Gerontol Geriatr Stud [Internet]. 2018;2(1):e000529. 10.31031/GGS.2018.02.000529 - DOI
-
- Leelakanok N, D'Cunha RR. Association between polypharmacy and dementia – a systematic review and metaanalysis. Aging Ment Health. 2019;23(8):932–941. - PubMed
LinkOut - more resources
Full Text Sources